Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
J Thorac Dis
.
2020 May;12(5):2706-2712.
doi: 10.21037/jtd.2020.04.30.
Authors
Mike Sung
1
,
Alona Zer
1
,
Preet Walia
1
,
Leila Khoja
2
,
Manjula Maganti
1
,
Catherine Labbe
3
,
Frances A Shepherd
1
,
Penelope A Bradbury
1
,
Geoffrey Liu
1
,
Natasha B Leighl
1
Affiliations
1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
2
Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.
3
Institut Universitaire de Cardiologie de Pneumologie de Québec, 2725 Chemin Ste-Foy, Québec, Canada.
PMID:
32642178
PMCID:
PMC7330321
DOI:
10.21037/jtd.2020.04.30
No abstract available